Patriot News Organization

(HealthDay)—A return to non-contact physical activity three days after a concussion is safe and possibly even beneficial for kids, a Canadian clinical trial finds. “Gone are the days of resting in a dark room,” said study co-author Andrée-Anne Ledoux, a…

More proof pollution damages sperm: Men living in areas with most toxic air have swimmers of poorer quality, study claims Chinese researchers analysed the swimmers from almost 34,000 men in cities Results showed sperm motility – or movement – was…

Optical genome mapping involves the extraction of very long DNA molecules, for example routinely collected blood samples or bone marrow material from patients. These long DNA molecules are labeled with dye molecules at more than half a million different positions…

A small study suggests that treating patients who have moderate or severe COVID-19 with ceftazidime or cefepime, plus the steroid dexamethasone, is as effective as standard care. The antibiotic-plus-steroid treatment was associated with fewer side effects compared with standard care,…

Dementia: Dr Sara on benefits of being in nature We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our…

In a recent study posted to the medRxiv* pre-print server, a team of researchers examined the neurotoxic damage to the brain’s cortical region in patients hospitalized due to coronavirus disease 2019 (COVID-19).  Study: Brain cortical changes are related to inflammatory…

Heart disease: Doctor explains how to reduce risk We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding….

The potential utility of neutralizing antibodies as anti-viral treatments have led many researchers to study the humoral immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Potent neutralizing antibodies primarily target epitopes on the spike (S) glycoprotein of…

There’s a new drug to treat Alzheimer’s disease, but those who might benefit from it know almost nothing about it, a new study shows. In spring 2021, for the first time in decades, the U.S. Food and Drug Administration approved…

It started as a secret shared with a patient. A nurse at The Moses H. Cone Memorial Hospital in Greensboro, North Carolina, admitted she was pregnant — and when the information started making the rounds, one by one five other…